EUVIMEDEUVIMED entdecken
Crossref

Identification of CCL20 as a Prognostic Predictor for Severe Fever With Thrombocytopenia Syndrome Based on Plasma Proteomics

Yue Zhang iD, Lan Li, Yuanni Liu, Wei Zhang, Wenjuan Peng, Shuai Zhang, Renliang Qu, Yuan Ma, Zishuai Liu, Ziruo Ge, Yanxi Zhou, Wen Tian und 5 weitere

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiae039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Yue Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing…. Hauptthemen laut MEDLINE: Chemokine CCL20, Severe Fever with Thrombocytopenia Syndrome, Proteomics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Clinical Institutes and Departments of Capital Medical University, Beijing High-Level Public Health Technical Talent Training Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe fever with thrombocytopenia syndrome (SFTS), a lethal tick-borne hemorrhagic fever, prompted our investigation into prognostic predictors and potential drug targets using plasma Olink Proteomics.

Methods

Employing the Olink assay, we analyzed 184 plasma proteins in 30 survivors and 8 nonsurvivors of SFTS. Validation was performed in a cohort of 154 patients with SFTS via enzyme-linked immunosorbent assay. We utilized the Drug-Gene Interaction Database to identify protein-drug interactions.

Results

Nonsurvivors exhibited 110 differentially expressed proteins as compared with survivors, with functional enrichment in the cell chemotaxis–related pathway. Thirteen differentially expressed proteins—including C-C motif chemokine 20 (CCL20), calcitonin gene–related peptide alpha, and pleiotrophin—were associated with multiple-organ dysfunction syndrome. CCL20 emerged as the top predictor of death, demonstrating an area under the curve of 1 (P = .0004) and 0.9033 (P < .0001) in the discovery and validation cohorts, respectively. Patients with CCL20 levels exceeding 45.74 pg/mL exhibited a fatality rate of 45.65%, while no deaths occurred in those with lower CCL20 levels. Furthermore, we identified 202 Food and Drug Administration–approved drugs targeting 37 death-related plasma proteins.

Conclusions

Distinct plasma proteomic profiles characterize SFTS cases with different outcomes, with CCL20 emerging as a novel, sensitive, accurate, and specific biomarker for predicting SFTS prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemokine CCL20Severe Fever with Thrombocytopenia SyndromeProteomicsHumansFemalePrognosisMaleAgedMiddle AgedBiomarkersAdultAged, 80 and overCohort Studies

Stichwörter der Autor:innen

C-C motif chemokine 20plasma proteomicsprognostic predictorsevere fever with thrombocytopenia syndrome

Substanzen

Chemokine CCL20CCL20 protein, humanBiomarkers

Autor:innen und Institutionen

  • Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Beijing Institute of Infectious Diseases, Beijing, China.
  • National Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Department of Infectious Diseases, Yantai City Hospital for Infectious Disease, Yantai, China.
  • Department of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Department of Clinical Laboratory, Yantai City Hospital for Infectious Disease, Yantai, China.

ORCID-Profile: Yue Zhang, Liuluan Zhu

Förderung

  • National Natural Science Foundation of China
  • Clinical Institutes and Departments of Capital Medical University
  • Beijing High-Level Public Health Technical Talent Training Program

Zitieren

APA

Zhang, Y., Li, L., Liu, Y., Zhang, W., Peng, W., Zhang, S., Qu, R., Ma, Y., Liu, Z., Ge, Z., Zhou, Y., Tian, W., Shen, Y., Liu, L., Duan, J., Chen, Z., & Zhu, L. (2024). Identification of CCL20 as a Prognostic Predictor for Severe Fever With Thrombocytopenia Syndrome Based on Plasma Proteomics. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae039

Vancouver

Zhang Y, Li L, Liu Y, Zhang W, Peng W, Zhang S, et al. Identification of CCL20 as a Prognostic Predictor for Severe Fever With Thrombocytopenia Syndrome Based on Plasma Proteomics. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae039

BibTeX
@article{Zhang2024,
  author = {Zhang, Yue and Li, Lan and Liu, Yuanni and Zhang, Wei and Peng, Wenjuan and Zhang, Shuai and Qu, Renliang and Ma, Yuan and Liu, Zishuai and Ge, Ziruo and Zhou, Yanxi and Tian, Wen and Shen, Yi and Liu, Li and Duan, Jianping and Chen, Zhihai and Zhu, Liuluan},
  title = {Identification of CCL20 as a Prognostic Predictor for Severe Fever With Thrombocytopenia Syndrome Based on Plasma Proteomics},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiae039}
}
Kostenlos starten →